| An insight into the medicinal perspective of synthetic analogs of indole: A review PV Thanikachalam, RK Maurya, V Garg, V Monga European journal of medicinal chemistry 180, 562-612, 2019 | 246 | 2019 |
| Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines A Nayyar, V Monga, A Malde, E Coutinho, R Jain Bioorganic & medicinal chemistry 15 (2), 626-640, 2007 | 192 | 2007 |
| Recent advances in the synthetic and medicinal perspective of quinolones: A review P Dhiman, N Arora, PV Thanikachalam, V Monga Bioorganic Chemistry 92, 103291, 2019 | 114 | 2019 |
| Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors S Kumar, S Rulhania, S Jaswal, V Monga European journal of medicinal chemistry 209, 112923, 2021 | 100 | 2021 |
| Recent advancements in the development of bioactive pyrazoline derivatives B Nehra, S Rulhania, S Jaswal, B Kumar, G Singh, V Monga European journal of medicinal chemistry 205, 112666, 2020 | 94 | 2020 |
| Recent advancements in the development of heterocyclic anti-inflammatory agents S Sharma, D Kumar, G Singh, V Monga, B Kumar European Journal of Medicinal Chemistry 200, 112438, 2020 | 86 | 2020 |
| Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues V Monga, A Nayyar, B Vaitilingam, PB Palde, SS Jhamb, S Kaur, ... Bioorganic & medicinal chemistry 12 (24), 6465-6472, 2004 | 75 | 2004 |
| Recent advances in synthesis and medicinal chemistry of benzodiazepines N Arora, P Dhiman, S Kumar, G Singh, V Monga Bioorganic Chemistry 97, 103668, 2020 | 74 | 2020 |
| Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs V Monga, CL Meena, N Kaur, R Jain Current medicinal chemistry 15 (26), 2718-2733, 2008 | 71 | 2008 |
| An insight into the medicinal attributes of berberine derivatives: A review S Gaba, A Saini, G Singh, V Monga Bioorganic & medicinal chemistry 38, 116143, 2021 | 70 | 2021 |
| Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1 B Vaitilingam, A Nayyar, PB Palde, V Monga, R Jain, S Kaur, PP Singh Bioorganic & medicinal chemistry 12 (15), 4179-4188, 2004 | 64 | 2004 |
| Synthesis and evaluation of new chalcones, derived pyrazoline and cyclohexenone derivatives as potent antimicrobial, antitubercular and antileishmanial agents V Monga, K Goyal, M Steindel, M Malhotra, DP Rajani, SD Rajani Medicinal chemistry research 23, 2019-2032, 2014 | 57 | 2014 |
| Synthesis and biological evaluation of thiazolidine-2, 4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents G Bansal, S Singh, V Monga, PV Thanikachalam, P Chawla Bioorganic chemistry 92, 103271, 2019 | 54 | 2019 |
| Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme … S Mehan, V Monga, M Rani, R Dudi, K Ghimire Indian journal of pharmacology 50 (6), 309-319, 2018 | 53 | 2018 |
| Medicinal perspective of indole derivatives: recent developments and structure-activity relationship studies D Kumar, S Sharma, S Kalra, G Singh, V Monga, B Kumar Current drug targets 21 (9), 864-891, 2020 | 52 | 2020 |
| Low affinity analogs of thyrotropin-releasing hormone are super-agonists S Engel, S Neumann, N Kaur, V Monga, R Jain, J Northup, ... Journal of Biological Chemistry 281 (19), 13103-13109, 2006 | 41 | 2006 |
| p53-Mdm2 interaction inhibitors as novel nongenotoxic anticancer agents SK Nayak, GL Khatik, R Narang, V Monga, HK Chopra Current cancer drug targets 18 (8), 749-772, 2018 | 40 | 2018 |
| Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted pyrazolyl thiazolidinediones as potent pancreatic lipase inhibitors SNC Sridhar, D Bhurta, D Kantiwal, G George, V Monga, AT Paul Bioorganic & medicinal chemistry letters 27 (16), 3749-3754, 2017 | 39 | 2017 |
| Aurora kinase inhibitors as potential anticancer agents: Recent advances T Pradhan, O Gupta, G Singh, V Monga European Journal of Medicinal Chemistry 221, 113495, 2021 | 36 | 2021 |
| Adenosine receptor antagonists: Recent advances and therapeutic perspective A Saini, R Patel, S Gaba, G Singh, GD Gupta, V Monga European Journal of Medicinal Chemistry 227, 113907, 2022 | 35 | 2022 |
Gurpreet SinghISF College of pharmacyDirección de correo verificada de isfcp.org
